review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029165610 |
P356 | DOI | 10.1007/S12026-010-8201-Y |
P932 | PMC publication ID | 3366695 |
P698 | PubMed publication ID | 21203905 |
P5875 | ResearchGate publication ID | 49726695 |
P50 | author | Svetlana P Chapoval | Q56871272 |
P2093 | author name string | EusebiusHenry Nkyimbeng-Takwi | |
P2860 | cites work | Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates | Q22010646 |
Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration | Q24290930 | ||
CD72 negatively regulates KIT-mediated responses in human mast cells | Q24297400 | ||
CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis | Q80142605 | ||
Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively | Q81475161 | ||
Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis | Q82354361 | ||
Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice | Q84334793 | ||
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1 | Q24298191 | ||
Structure and function of the intracellular region of the plexin-b1 transmembrane receptor | Q24309186 | ||
Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns | Q24311901 | ||
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation | Q24314914 | ||
A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor | Q24318269 | ||
Identification of antigenic epitopes on human allergens: studies with HLA transgenic mice | Q24813616 | ||
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D | Q27641965 | ||
Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family | Q27644081 | ||
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling | Q28140151 | ||
BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking | Q28144881 | ||
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 | ||
Immune semaphorins: a new area of semaphorin research | Q28191419 | ||
Functional regulation of semaphorin receptors by proprotein convertases | Q28203827 | ||
HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages | Q28204428 | ||
Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis | Q28205197 | ||
CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes | Q28212106 | ||
PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis | Q28212775 | ||
The semaphorin 4D receptor controls invasive growth by coupling with Met | Q28219215 | ||
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation | Q28276903 | ||
Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins | Q28294177 | ||
CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion | Q28299135 | ||
Identification of a novel transmembrane semaphorin expressed on lymphocytes | Q28299736 | ||
Sema4D induces angiogenesis through Met recruitment by Plexin B1 | Q28301113 | ||
Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension | Q28301321 | ||
Sema4A induces cell morphological changes through B-type plexin-mediated signaling | Q28506174 | ||
Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice | Q28585413 | ||
Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100 | Q29036802 | ||
Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis | Q30494712 | ||
Tim-2 regulates T helper type 2 responses and autoimmunity | Q33220331 | ||
Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis | Q33285431 | ||
Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. | Q33496364 | ||
Plexina1 autoinhibition by the plexin sema domain. | Q33937108 | ||
CD72, a negative regulator of B-cell responsiveness | Q34067317 | ||
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. | Q34154039 | ||
The CD100-CD72 interaction: a novel mechanism of immune regulation | Q34460685 | ||
Structure determination of human semaphorin 4D as an example of the use of MAD in non-optimal cases | Q34478515 | ||
Neovascularization in human atherosclerosis | Q34523545 | ||
MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. | Q34598008 | ||
Controlling the immune system through semaphorins | Q34611960 | ||
Mastocytosis: state of the art. | Q34641105 | ||
Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. | Q34694762 | ||
The semaphorins | Q35012897 | ||
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury | Q35616359 | ||
The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas | Q35753111 | ||
The sema domain | Q35975030 | ||
Mast cell and immune inhibitory receptors | Q36315238 | ||
Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation | Q36370576 | ||
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis | Q36403570 | ||
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages | Q36742291 | ||
TIM family proteins and autoimmunity. | Q36922976 | ||
Semaphorins and their receptors in immune cell interactions. | Q37034914 | ||
Cutting edge: inhibition of T cell activation by TIM-2. | Q40224859 | ||
Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells | Q40554915 | ||
The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity. | Q41091144 | ||
Semaphorin III is needed for normal patterning and growth of nerves, bones and heart | Q41159467 | ||
Inhibitory receptors, ITIM sequences and phosphatases | Q41514609 | ||
Biochemical identity of the mouse Ly-19.2 and Ly-32.2 alloantigens with the B cell differentiation antigen Lyb-2/CD72. | Q41515289 | ||
New roles for TIM family members in immune regulation | Q44470505 | ||
Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. | Q45003993 | ||
Vascular endothelial growth factor enhances atherosclerotic plaque progression | Q46656974 | ||
The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice | Q49157483 | ||
The transmembrane Semaphorin Sema I is required in Drosophila for embryonic motor and CNS axon guidance. | Q52190093 | ||
Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. | Q52204570 | ||
Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation. | Q54001263 | ||
Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. | Q54468855 | ||
The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion | Q56914645 | ||
Myocarditis | Q56933171 | ||
Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb | Q72159408 | ||
CD72 negatively regulates signaling through the antigen receptor of B cells | Q73368116 | ||
A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members | Q73790404 | ||
Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells | Q74500047 | ||
CD100 is a leukocyte semaphorin | Q77668599 | ||
Involvement of Sema4A in the progression of experimental autoimmune myocarditis | Q79770255 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10-21 | |
P577 | publication date | 2011-05-01 | |
P1433 | published in | Immunologic Research | Q15754981 |
P1476 | title | Biology and function of neuroimmune semaphorins 4A and 4D | |
P478 | volume | 50 |
Q35577716 | A live-cell, high-content imaging survey of 206 endogenous factors across five stress conditions reveals context-dependent survival effects in mouse primary beta cells |
Q57490032 | CD100 Effects in Macrophages and Its Roles in Atherosclerosis |
Q55314129 | CD100/Sema4D Increases Macrophage Infection by Leishmania (Leishmania) amazonensis in a CD72 Dependent Manner. |
Q39134695 | Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo |
Q89453286 | Class 4 Semaphorins and Plexin-B receptors regulate GABAergic and glutamatergic synapse development in the mammalian hippocampus |
Q34769181 | Familial 1q22 microduplication associated with psychiatric disorders, intellectual disability and late-onset autoimmune inflammatory response |
Q30459493 | Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems. |
Q42393761 | Generation and preclinical characterization of an antibody specific for SEMA4D. |
Q50325168 | Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4. |
Q90602341 | Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study |
Q38073228 | Immune plexins and semaphorins: old proteins, new immune functions |
Q90224923 | Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis |
Q60925221 | Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor? |
Q24601341 | Neuroimmune semaphorin 4A downregulates the severity of allergic response |
Q28295886 | Neuroimmune semaphorin 4D is necessary for optimal lung allergic inflammation |
Q64964739 | Overexpression of Semaphorin-3A and Semaphorin-4D in the Peripheral Blood from Newly Diagnosed Patients with Chronic Lymphocytic Leukemia. |
Q90927802 | Reciprocal changes in CD11c+CD11b+ and CD11c+CD8α+ dendritic cell subsets determine protective or permissive immune response in murine experimental VL |
Q34273462 | Retracted: Placental Expression of CD100, CD72 and CD45 Is Dysregulated in Human Miscarriage |
Q40324097 | Saturation monitoring of VX15/2503, a novel semaphorin 4D-specific antibody, in clinical trials |
Q43185176 | Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis. |
Q37479013 | Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses. |
Q61797424 | Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo |
Q38935490 | Semaphorins 4A and 4D in chronic inflammatory diseases. |
Q38235876 | Semaphorins and plexins as therapeutic targets |
Q38080487 | Semaphorins: their dual role in regulating immune-mediated diseases |
Q38833914 | Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth |
Q35610857 | The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). |
Q38687505 | The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases. |
Q47104862 | View Point: Semaphorin-3E: An Emerging Modulator of Natural Killer Cell Functions? |
Q38633204 | Whole transcriptome profiling of taste bud cells |